When we look at how much money they make before expenses, they keep 0.522% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.150%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.206%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust 0.077% return, is a testament to Shin Nippon Biomedical Laboratories, Ltd.'s adeptness in optimizing resource deployment. Shin Nippon Biomedical Laboratories, Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.192%. Furthermore, the proficiency of Shin Nippon Biomedical Laboratories, Ltd. in capital utilization is underscored by a remarkable 0.082% return on capital employed.
Stock Prices
Shin Nippon Biomedical Laboratories, Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $1547, while its low point bottomed out at $1516. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Shin Nippon Biomedical Laboratories, Ltd.'s stock market.
Liquidity Ratios
Analyzing 2395.T liquidity ratios reveals its financial health of the firm.
The current ratio of 149.55% gauges short-term asset coverage for liabilities.
The quick ratio (83.46%) assesses immediate liquidity, while the cash ratio (57.15%) indicates cash reserves.
cards.indicator
cards.value
Current Ratio
149.55%
Quick Ratio
83.46%
Cash Ratio
57.15%
Profitability Ratios
2395.T profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 26.46% underscores its earnings before tax deductions.
The effective tax rate stands at 22.16%, revealing its tax efficiency.
The net income per EBT, 77.87%, and the EBT per EBIT, 176.79%, provide insights into its earnings hierarchy.
Lastly, with an EBIT per revenue ratio of 14.97%, we grasp its operational profitability.
cards.indicator
cards.value
Pretax Profit Margin
26.46%
Effective Tax Rate
22.16%
Net Income per EBT
77.87%
EBT per EBIT
176.79%
EBIT per Revenue
14.97%
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 1.50, it details the span from stock purchase to revenue.
The 1 days it takes to settle debts showcases its creditor relations.
Meanwhile, a 1 cash conversion cycle and 471.76% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.
cards.indicator
cards.value
Days of Sales Outstanding
83
Days of Inventory Outstanding
341
Operating Cycle
418.60
Days of Payables Outstanding
16
Cash Conversion Cycle
403
Receivables Turnover
4.72
Payables Turnover
22.68
Inventory Turnover
1.07
Fixed Asset Turnover
1.25
Asset Turnover
0.37
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 85.79, and free cash flow per share, 85.79, depict cash generation on a per-share basis.
The cash per share value, 312.32, showcases liquidity position.
Lastly, the operating cash flow sales ratio, 0.13, offers insight into cash flow relative to sales.
cards.indicator
cards.value
Operating Cash Flow per Share
85.79
Free Cash Flow per Share
85.79
Cash per Share
312.32
Operating Cash Flow Sales Ratio
0.13
Free Cash Flow to Operating Cash Flow Ratio
1.00
Cash Flow Coverage Ratio
0.13
Short Term Coverage Ratio
0.45
Debt and Leverage Ratios
Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 37.39%, highlights its total liabilities relative to assets.
With a debt-equity ratio of 0.88, we discern the balance between debt and equity financing.
The long-term debt to capitalization, 38.23%, and total debt to capitalization, 46.93%, ratios shed light on its capital structure.
An interest coverage of 30.41 indicates its ability to manage interest expenses.
cards.indicator
cards.value
Debt Ratio
37.39%
Debt Equity Ratio
0.88
Long Term Debt to Capitalization
38.23%
Total Debt to Capitalization
46.93%
Interest Coverage
30.41
Cash Flow to Debt Ratio
0.13
Company Equity Multiplier
2.36
Growth Ratios
Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 17.46%, indicates top-line expansion, while the gross profit growth, 28.23%, reveals profitability trends.
EBIT growth, 96.52%, and operating income growth, 96.52%, offer insights into operational profitability progression.
The net income growth, 65.49%, showcases bottom-line expansion, and the EPS growth, 94.63%, measures the growth in earnings per share.
cards.indicator
cards.value
Revenue Growth
17.46%
Gross Profit Growth
28.23%
EBIT Growth
96.52%
Operating Income Growth
96.52%
Net Income Growth
65.49%
EPS Growth
94.63%
EPS Diluted Growth
94.63%
Dividends per Share Growth
300.75%
Operating Cash Flow Growth
25.41%
Free Cash Flow Growth
19.56%
10-Year Revenue Growth per Share
-14.65%
5-Year Revenue Growth per Share
6.92%
3-Year Revenue Growth per Share
13.35%
10-Year Operating CF Growth per Share
5338.65%
5-Year Operating CF Growth per Share
342.83%
3-Year Operating CF Growth per Share
105.79%
10-Year Net Income Growth per Share
533.62%
5-Year Net Income Growth per Share
270.42%
3-Year Net Income Growth per Share
210.72%
10-Year Shareholders Equity Growth per Share
494.38%
5-Year Shareholders Equity Growth per Share
-25.22%
3-Year Shareholders Equity Growth per Share
-31.14%
10-Year Dividend per Share Growth per Share
58125.43%
3-Year Dividend per Share Growth per Share
568.84%
Receivables Growth
18.53%
Inventory Growth
7.08%
Asset Growth
6.33%
Book Value per Share Growth
24.32%
Debt Growth
-27.97%
R&D Expense Growth
8.37%
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.88, and the price to book ratio, 1.88, reflect the market's valuation relative to the company's book value.
The price to sales ratio, 2.13, provides a perspective on valuation in relation to sales.
Ratios like price to free cash flows, 15.92, and price to operating cash flows, 15.92, gauge market valuation against cash flow metrics.
cards.indicator
cards.value
Price Book Value Ratio
1.88
Price to Book Ratio
1.88
Price to Sales Ratio
2.13
Price Cash Flow Ratio
15.92
Price Earnings to Growth Ratio
-0.08
Enterprise Value Multiple
5.86
Price Fair Value
1.88
Price to Operating Cash Flow Ratio
15.92
Price to Free Cash Flows Ratio
15.92
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
